Cargando…
Association Between Acid-Suppressive Agents’ Use and Risk of Hepatocellular Carcinoma
BACKGROUND: Acid-suppressive agents (ASAs), which are mostly used in patients with upper gastrointestinal diseases (UGIDs), may influence the risk of hepatocellular carcinoma (HCC). METHODS: A population-based retrospective cohort study was conducted. Patients with UGID who used ASAs and those who d...
Autores principales: | Lin, Hsiu C., Hsu, Huan Y., Lin, Hsiu L., Uang, Yow S., Ho, Yi, Wang, Li H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851131/ https://www.ncbi.nlm.nih.gov/pubmed/35185412 http://dx.doi.org/10.1177/1559325820907530 |
Ejemplares similares
-
Use of gastric acid–suppressive agents increases the risk of dementia in patients with upper gastrointestinal disease: A population-based retrospective cohort study
por: Lin, Hsiu-Chen, et al.
Publicado: (2021) -
Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation
por: Cheng, He-Yun, et al.
Publicado: (2022) -
Association Between Use of Antihyperlipidemic Agents and Chronic Obstructive Pulmonary Disease in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study
por: Lei, Yi-Fen, et al.
Publicado: (2020) -
The use of proton pump inhibitors decreases the risk of diabetes mellitus in patients with upper gastrointestinal disease: A population-based retrospective cohort study
por: Lin, Hsiu-Chen, et al.
Publicado: (2016) -
Daily aspirin associated with a reduced risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a population-based cohort study
por: Lee, Teng-Yu, et al.
Publicado: (2023)